Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare
Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
During the COVID-19 pandemic, many hospital wards were temporarily converted to solely treat COVID-19 patients. As these begin to revert back to ‘regular’ non COVID-19 wards, a solution is required to manage the increased potential contamination risk facing the patients admitted to these wards.
Our latest case study highlights how Bioquell’s RBDS recently returned an emergency COVID-19 hospital ward in the UK back to normal use with little or no interruption to surrounding areas.
For the full case study, click here.